Akiyoshi Tani

843 citations

21 papers · 564 indexed · h-index 13

Endocrinology, Diabetes and Metabolism top 10%
- Diabetes Treatment and Management 4
Cellular and Molecular Neuroscience
- Neuropeptides and Animal Physiology 6
Oncology
- Peptidase Inhibition and Analysis 5
Cardiology and Cardiovascular Medicine
Organic Chemistry
Genetics
- Virus-based gene therapy research 2
Molecular Biology
- RNA Interference and Gene Delivery 2
- Melanoma and MAPK Pathways 2
- Peroxisome Proliferator-Activated Receptors 2
- Metabolism, Diabetes, and Cancer 2

Co-authors: Kotaro Sakamoto Yusuke Kamada Junichi Sakamoto Tomoari Kamada Yuzo Yamasaki Mineo Kodama Miyuki Funami Munehide Matsuhisa
Cited by: Endocrinology, Diabetes and Metabolism Cellular and Molecular Neuroscience Oncology
Journals: PLoS ONE (1 paper)Scientific Reports (1 paper)Biochemical and Biophysical Research Communications (3 papers)
Partner nations: Japan United States Italy

In The Last Decade

Akiyoshi Tani

21 papers receiving 547 citations

Peers

Countries citing papers authored by Akiyoshi Tani

Since Specialization

Citations

This map shows the geographic impact of Akiyoshi Tani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Akiyoshi Tani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Akiyoshi Tani more than expected).

Fields of papers citing papers by Akiyoshi Tani

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Akiyoshi Tani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Akiyoshi Tani. The network helps show where Akiyoshi Tani may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Akiyoshi Tani, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Akiyoshi Tani Line = papers co-authored together Akiyoshi Tani links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Tetracyclines enhance antitumor T-cell immunity via the Zap70 signaling pathway Journal for ImmunoTherapy of Cancer ·Mari Tone,Kota Iwahori,Michinari Hirata,Azumi Ueyama,Akiyoshi Tani,Jun‐ichi Haruta,Yoshito Takeda,Yasushi Shintani,Atsushi Kumanogoh,Hisashi Wada	2024	6
2	Synthesis and biochemical characterization of naphthoquinone derivatives targeting bacterial histidine kinases The Journal of Antibiotics ·Teruhiko Ishikawa,Yoko Eguchi,Masayuki Igarashi,Toshihide Okajima,Kohei Mita,Yuri Yamasaki,K. Sumikura,Taisei Okumura,Yuna Τabuchi,Chigusa Hayashi,Martina Pasqua,Marco Coluccia,Gianni Prosseda,Bianca Colonna,Chie Kohayakawa,Akiyoshi Tani,Jun-ichi Haruta,Ryutaro Utsumi	2024	2
3	Microtubule inhibitors identified through nonbiased screening enhance DNA transfection efficiency by delaying p62‐dependent ubiquitin recruitment Genes to Cells ·Megumi Tsuchiya,Hidesato Ogawa,Kento Watanabe,Takako Koujin,Chie Mori,Kazuto Nunomura,Bangzhong Lin,Akiyoshi Tani,Yasushi Hiraoka,Tokuko Haraguchi	2021	3
4	Establishment of a novel human CIC-DUX4 sarcoma cell line, Kitra-SRS, with autocrine IGF-1R activation and metastatic potential to the lungs Scientific Reports ·Sho Nakai,Shutaro Yamada,Hidetatsu Outani,Takaaki Nakai,Naohiro Yasuda,Hirokazu Mae,Yoshinori Imura,Toru Wakamatsu,Hironari Tamiya,Takaaki Tanaka,Kenichiro Hamada,Akiyoshi Tani,Akira Myoui,Nobuhito Araki,Takafumi Ueda,Hideki Yoshikawa,Satoshi Takenaka,Norifumi Naka	2019	16
5	Discovery of artificial VIPR2-antagonist peptides possessing receptor- and ligand-selectivity Biochemical and Biophysical Research Communications ·Kotaro Sakamoto,Ryokichi Koyama,Yusuke Kamada,Masanori Miwa,Akiyoshi Tani	2018	12
6	Identification of cytidine-5-triphosphate synthase1-selective inhibitory peptide from random peptide library displayed on T7 phage Peptides ·Kotaro Sakamoto,Yoshihiro Ishibashi,Ryutaro Adachi,Shin-ichi Matsumoto,Hideyuki Oki,Yusuke Kamada,Satoshi Sogabe,Yumi Zama,Junichi Sakamoto,Akiyoshi Tani	2017	6
7	Investigation on cellular uptake and pharmacodynamics of DOCK2-inhibitory peptides conjugated with cell-penetrating peptides Bioorganic & Medicinal Chemistry ·Yusuke Adachi,Kotaro Sakamoto,T. Umemoto,Yasunori Fukuda,Akiyoshi Tani,Taiji Asami	2017	8
8	Design of potent dipeptidyl peptidase IV (DPP-4) inhibitors by employing a strategy to form a salt bridge with Lys554 Bioorganic & Medicinal Chemistry Letters ·Hironobu Maezaki,Michiko Tawada,Takashi Yamashita,Yoshihiro Banno,Yasufumi Miyamoto,Yoshio Yamamoto,Koji Ikedo,Takuo Kosaka,Shigetoshi Tsubotani,Akiyoshi Tani,Tomoko Asakawa,Nobuhiro Suzuki,Satoru Oi	2017	17
9	K-Ras(G12D)-selective inhibitory peptides generated by random peptide T7 phage display technology Biochemical and Biophysical Research Communications ·Kotaro Sakamoto,Yusuke Kamada,Tomoya Sameshima,Masahiro Yaguchi,Ayumu Niida,Shigekazu Sasaki,Masanori Miwa,Shoichi Ohkubo,Junichi Sakamoto,Masahiro Kamaura,Nobuo Cho,Akiyoshi Tani	2017	88
10	Trelagliptin (SYR-472, Zafatek), Novel Once-Weekly Treatment for Type 2 Diabetes, Inhibits Dipeptidyl Peptidase-4 (DPP-4) via a Non-Covalent Mechanism PLoS ONE ·Charles E. Grimshaw,Andy Jennings,Ruhi Kamran,Hikaru Ueno,Nobuhiro Nishigaki,Takuo Kosaka,Akiyoshi Tani,Hiroki Sano,Yoshinobu Kinugawa,Emiko Koumura,Lihong Shi,Koji Takeuchi	2016	43
11	Discovery of GPX4 inhibitory peptides from random peptide T7 phage display and subsequent structural analysis Biochemical and Biophysical Research Communications ·Kotaro Sakamoto,Satoshi Sogabe,Yusuke Kamada,Shin-ichi Matsumoto,Akito Kadotani,Junichi Sakamoto,Akiyoshi Tani	2016	46
12	Design, synthesis, and structure–activity relationships of novel spiro-piperidines as acetyl-CoA carboxylase inhibitors Bioorganic & Medicinal Chemistry Letters ·Makoto Kamata,Takashi Yamashita,Asato Kina,Masaaki Funata,Atsushi Mizukami,Masako Sasaki,Akiyoshi Tani,Miyuki Funami,Nobuyuki Amano,K. Fukatsu	2012	46
13	Symmetrical approach of spiro-pyrazolidinediones as acetyl-CoA carboxylase inhibitors Bioorganic & Medicinal Chemistry Letters ·Makoto Kamata,Takashi Yamashita,Asato Kina,Michiko Tawada,Satoshi Endo,Atsushi Mizukami,Masako Sasaki,Akiyoshi Tani,Yoshihide Nakano,Yuuki Watanabe,Naoki Furuyama,Miyuki Funami,Nobuyuki Amano,K. Fukatsu	2012	35
14	Design, synthesis, and structure–activity relationships of spirolactones bearing 2-ureidobenzothiophene as acetyl-CoA carboxylases inhibitors Bioorganic & Medicinal Chemistry Letters ·Takashi Yamashita,Makoto Kamata,Satoshi Endo,Mitsuo Yamamoto,Keiko Kakegawa,Hiroyuki Watanabe,Katsuhiko Miwa,Toru Yamano,Masaaki Funata,Jyun-Ichi Sakamoto,Akiyoshi Tani,Clifford D. Mol,Hua Zou,Douglas R. Dougan,Bi‐Ching Sang,G. Snell,K. Fukatsu	2011	16
15	Discovery of potent, selective, and orally bioavailable quinoline-based dipeptidyl peptidase IV inhibitors targeting Lys554 Bioorganic & Medicinal Chemistry ·Hironobu Maezaki,Yoshihiro Banno,Yasufumi Miyamoto,Yuusuke Moritou,Tomoko Asakawa,Osamu Kataoka,Koji Takeuchi,Nobuhiro Suzuki,Koji Ikedo,Takuo Kosaka,Masako Sasaki,Shigetoshi Tsubotani,Akiyoshi Tani,Miyuki Funami,Yoshio Yamamoto,Michiko Tawada,Kathleen Aertgeerts,Jason K. Yano,Satoru Oi	2011	28
16	Identification of 3-aminomethyl-1,2-dihydro-4-phenyl-1-isoquinolones: A new class of potent, selective, and orally active non-peptide dipeptidyl peptidase IV inhibitors that form a unique interaction with Lys554 Bioorganic & Medicinal Chemistry ·Yoshihiro Banno,Yasufumi Miyamoto,Mitsuru Sasaki,Satoru Oi,Tomoko Asakawa,Osamu Kataoka,Koji Takeuchi,Nobuhiro Suzuki,Koji Ikedo,Takuo Kosaka,Shigetoshi Tsubotani,Akiyoshi Tani,Miyuki Funami,Michiko Tawada,Yoshio Yamamoto,Kathleen Aertgeerts,Jason K. Yano,Hironobu Maezaki	2011	40
17	Design and synthesis of 3-pyridylacetamide derivatives as dipeptidyl peptidase IV (DPP-4) inhibitors targeting a bidentate interaction with Arg125 Bioorganic & Medicinal Chemistry ·Yasufumi Miyamoto,Yoshihiro Banno,Takashi Yamashita,Tatsuhiko Fujimoto,Satoru Oi,Yusuke Moritoh,Tomoko Asakawa,Osamu Kataoka,Koji Takeuchi,Nobuhiro Suzuki,Koji Ikedo,Takuo Kosaka,Shigetoshi Tsubotani,Akiyoshi Tani,Miyuki Funami,Michiko Amano,Yoshio Yamamoto,Kathleen Aertgeerts,Jason K. Yano,Hironobu Maezaki	2010	23
18	Development of EIA systems for active-form MAP kinase Journal of Immunological Methods ·Akiyoshi Tani,Masakuni Noda,Yuzo Ichimori	2000	2
19	Allergic contact dermatitis due to beclometasone dipropionate in an inhalant for asthma. PubMed ·Akiyoshi Tani,Hayao Miyoshi,Tamotsu Kanzaki	2000	3
20	Increase in cytoplasmic free Ca2+ elicited by noradrenalin and serotonin in cultured local interneurons of mouse olfactory bulb Neuroscience ·Akiyoshi Tani,Yoshihiro Yoshihara,Kensaku Mori	1992	15

About Akiyoshi Tani

Akiyoshi Tani is a scholar working on Cellular and Molecular Neuroscience, Oncology and Toxicology, having authored 21 papers that have together received 564 indexed citations. Recurring topics across this work include Neuropeptides and Animal Physiology (6 papers), Peptidase Inhibition and Analysis (5 papers), Diabetes Treatment and Management (4 papers), Virus-based gene therapy research (2 papers), RNA Interference and Gene Delivery (2 papers), Melanoma and MAPK Pathways (2 papers), Peroxisome Proliferator-Activated Receptors (2 papers) and Metabolism, Diabetes, and Cancer (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (98 citations), Cellular and Molecular Neuroscience (86 citations) and Oncology (122 citations). Akiyoshi Tani has collaborated with scholars based in Japan, United States and Italy. Frequent co-authors include Kotaro Sakamoto, Yusuke Kamada, Junichi Sakamoto, Tomoari Kamada, Yuzo Yamasaki, Mineo Kodama, Miyuki Funami, Munehide Matsuhisa, Michihiko Kishimoto and Naohiko Ueda. Their work appears in journals such as PLoS ONE, Scientific Reports and Biochemical and Biophysical Research Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact